SEC 13F Intelligence

Boxer Capital, LLC / RLAY

Boxer Capital, LLC’s Relay Therapeutics Inc Position

Does Boxer Capital, LLC own Relay Therapeutics Inc (RLAY)? Not currently — the last reported position was 1.82M shares worth $13M in Q3 2024; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$13M
Q3 2024
Shares
1.82M
% of Portfolio
+0.63%
Quarters Held
17
position exited

Position History RLAY

Reported value by quarter
Q3 ’20: $53MQ3 ’20Q4 ’20: $54MQ1 ’21: $45MQ2 ’21: $47MQ2 ’21Q3 ’21: $41MQ4 ’21: $82MQ1 ’22: $80MQ1 ’22Q2 ’22: $45MQ3 ’22: $49MQ4 ’22: $32MQ4 ’22Q1 ’23: $35,726Q2 ’23: $22,848Q3 ’23: $15MQ3 ’23Q4 ’23: $20MQ1 ’24: $15MQ2 ’24: $12MQ2 ’24Q3 ’24: $13Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 20241.82M$13M+0.63%
Q2 20241.82M$12M+0.62%
Q1 20241.82M$15M+0.75%
Q4 20231.82M$20M+1.00%
Q3 20231.82M$15M+0.81%
Q2 20231.82M$22,848+1.06%
Q1 20232.17M$35,726+1.76%
Q4 20222.17M$32M+1.71%
Q3 20222.17M$49M+2.73%
Q2 20222.67M$45M+2.83%
Q1 20222.67M$80M+4.11%
Q4 20212.67M$82M+3.18%
Q3 20211.29M$41M+1.42%
Q2 20211.29M$47M+1.67%
Q1 20211.29M$45M+1.52%
Q4 20201.29M$54M+1.73%
Q3 20201.25M$53M+1.84%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of RLAY.